의료 관련 주식
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2027 | RAPP Rapport Therapeutics, Inc. - Common Stock | 40.13 USD | +0.50% | -4.59% | +6.30% | +53.23% | 1.92 B USD | ||
| 2028 | SNDA Sonida Senior Living, Inc. Common Stock | 40.51 USD | +3.42% | -0.05% | +16.44% | +57.20% | 1.92 B USD | ||
| 2032 | AAPG Ascentage Pharma Group International - American Depository Shar | 20.38 USD | +1.34% | +7.83% | +17.13% | -18.48% | 1.90 B USD | ||
| 2033 | NVCR NovoCure Limited - Ordinary Shares | 16.42 USD | +2.43% | -4.53% | +10.20% | +19.42% | 1.90 B USD | ||
| 2041 | PLSE Pulse Biosciences, Inc - Common Stock | 27.38 USD | +4.03% | +1.18% | +4.54% | +50.85% | 1.89 B USD | ||
| 2042 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.02 USD | -4.27% | -6.84% | +11.10% | +105.31% | 1.89 B USD | ||
| 2045 | ABCL AbCellera Biologics Inc. - Common Shares | 6.16 USD | -8.61% | -15.50% | +9.41% | +56.35% | 1.88 B USD | ||
| 2046 | TYRA Tyra Biosciences, Inc. - Common Stock | 31.61 USD | -2.38% | -3.63% | +5.44% | +120.43% | 1.88 B USD | ||
| 2048 | ANIP ANI Pharmaceuticals, Inc. - Common Stock | 81.92 USD | +1.36% | -2.50% | +1.14% | -13.43% | 1.86 B USD | ||
| 2050 | VRDN Viridian Therapeutics, Inc. - Common Stock | 18.03 USD | -5.40% | -10.70% | +5.13% | -19.69% | 1.86 B USD | ||
| 2052 | BHC Bausch Health Companies Inc. Common Stock | 4.95 USD | +1.23% | +1.64% | +3.34% | -24.08% | 1.85 B USD | ||
| 2057 | BFLY Butterfly Network, Inc. Class A Common Stock | 7.02 USD | -3.97% | -12.03% | -3.04% | +267.54% | 1.83 B USD | ||
| 2060 | WGS GeneDx Holdings Corp. - Class A Common Stock | 61.69 USD | -6.73% | -11.54% | +7.47% | -23.86% | 1.83 B USD | ||
| 2061 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.09 USD | +0.71% | +19.36% | +34.54% | +179.13% | 1.83 B USD | ||
| 2066 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 17.23 USD | -2.16% | -16.11% | +1.06% | +1.41% | 1.82 B USD | ||
| 2067 | NBTX Nanobiotix S.A. - ADSs | 37.53 USD | -6.08% | -9.94% | +4.98% | +635.88% | 1.82 B USD | ||
| 2069 | BCAX Bicara Therapeutics Inc. - Common Stock | 27.60 USD | -1.85% | -7.01% | +18.25% | +91.14% | 1.81 B USD | ||
| 2070 | STOK Stoke Therapeutics, Inc. - Common Stock | 29.11 USD | -2.67% | -11.33% | -5.85% | +125.14% | 1.81 B USD | ||
| 2074 | GHRS GH Research PLC - Ordinary Shares | 29.13 USD | +8.21% | +6.47% | +32.47% | +105.72% | 1.81 B USD | ||
| 2075 | ATRC AtriCure, Inc. - Common Stock | 35.62 USD | +3.13% | +2.33% | +27.08% | -6.09% | 1.80 B USD |
뉴스 의료 관련 주식
목요일 주목받은 주식: 넷플릭스, 스페이스X, 알파벳, 알코아 및 인튜이티브 서지컬
인튜이티브 서지컬, 2분기 실적 호조에도 주가 10% 급락
목요일 주목해야 할 주식: 유나이티드헬스, 애보트 래버러토리스, TSMC 등 5종목
다우 지수, 6월 PPI 발표 후 150p 급등···투자 심리 개선, 공포·탐욕 지수 ‘중립’ 영역
Paradigm, Katie Biber를 최고운영책임자(COO)로 임명하고 최고법무책임자(CLO)도 겸임
나스닥, 인플레이션 보고서 발표 후 200p 이상 상승···투자 심리 개선, 탐욕 지수 ‘공포’ 영역
인튜이티브 서지컬, 화요일 주가 7% 급락···52주 최저치 기록
Gainers 의료 관련 주식
GNPX Genprex, Inc. - Common Stock | 8.00 | +1532.65% |
SRZNW Surrozen, Inc. - Warrant | 0.0156 | +136.36% |
LIMNW Liminatus Pharma, Inc. - Warrants | 0.0837 | +67.40% |
LIMN Liminatus Pharma, Inc. - Class A Common Stock | 0.15 | +36.36% |
CDNA CareDx, Inc. - Common Stock | 40.34 | +35.60% |
ATAI AtaiBeckley Inc. - Common Stock | 7.15 | +33.40% |
BIAFW bioAffinity Technologies, Inc. - Warrant | 0.0999 | +23.33% |
APLM Apollomics Inc. - Class A Ordinary Shares | 23.27 | +21.26% |
Losers 의료 관련 주식
WGSWW GeneDx Holdings Corp. - Warrant | 0.0006 | -71.43% |
DRMAW Dermata Therapeutics, Inc. - Warrant | 0.0080 | -32.20% |
JAGX Jaguar Health, Inc. - Common Stock | 1.34 | -30.93% |
VIVS VivoSim Labs, Inc. - Common Stock | 0.61 | -28.24% |
MODD Modular Medical, Inc. - common stock | 3.24 | -22.67% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.46 | -20.69% |
ENLV Enlivex Ltd. - Ordinary Shares | 4.75 | -18.66% |
NXGLW NexGel, Inc - Warrant | 0.0262 | -17.87% |